BridgeMD
New treatment option for Cocaine Use Disorder
Official title CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations
ClinicalTrials.gov ID: NCT06050304
What this study is testing
What is 3 blood tests?
3 blood tests is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for cocaine use disorder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This research focuses on behavioral sensitization (BS) a specific behavioural disturbance in crack-cocaine addiction. The primary objective is to observe whether BS can be demonstrated in an ecological setting in crack dependent users by continuous actimetry for 3 weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \> 18 years
- Have a current crack-cocaine use disorder defined as Severe Intensity Use Disorder (6 or more DSM5 criteria), AND preferential use of rapid...
- Self-identified male or female (n=10 males, n=10 females)
- Negative pregnancy test for females and use of effective contraception
- Be affiliated with a social security plan (or PUMA or CSS or AME)
You likely can't join if
- Patient with a psychiatric disorder or symptoms that are not currently stabilized
- Patient who is a minor or under protective supervision (curatorship or guardianship)
- Patient in care at the request of a judicial authority (therapeutic injunction, classification with orientation)
- Pregnant or breastfeeding women
- Patients who do not speak French or English sufficiently
- Patients weighing less than 40 kg
See the full eligibility criteria
- \> 18 years
- Have a current crack-cocaine use disorder defined as Severe Intensity Use Disorder (6 or more DSM5 criteria), AND preferential use of rapid administration route (intravenous or smoked)
- Self-identified male or female (n=10 males, n=10 females)
- Negative pregnancy test for females and use of effective contraception
- Be affiliated with a social security plan (or PUMA or CSS or AME)
- Sign an informed consent and commit to a 3-week follow-up in the study
- Have a weight greater than 40 kg
- Patient with a psychiatric disorder or symptoms that are not currently stabilized
- Patient who is a minor or under protective supervision (curatorship or guardianship)
- Patient in care at the request of a judicial authority (therapeutic injunction, classification with orientation)
- Pregnant or breastfeeding women
- Patients who do not speak French or English sufficiently
- Patients weighing less than 40 kg
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.